Rapamycin delays allograft rejection in obese graft recipients through induction of myeloid-derived suppressor cells.
Deißler A, Della Penna A, van Geffen C, Gonzalez-Menendez I, Quintanilla-Martinez L, Günther A, Schneiderhan-Marra N, Hartl D, Nürnberg B, Königsrainer A, Kolahian S, Quante M.
Deißler A, et al. Among authors: van geffen c.
Immunol Lett. 2021 Aug;236:1-11. doi: 10.1016/j.imlet.2021.05.003. Epub 2021 May 17.
Immunol Lett. 2021.
PMID: 34015361